Mankind Pharma Board to Consider Fund Raising
By Rediff Money Desk, New Delhi Sep 17, 2024 21:55
Mankind Pharma's board will meet this week to discuss raising funds through an issue of securities, including non-convertible debentures, commercial papers, and other debt securities.
New Delhi, Sep 17 (PTI) Mankind Pharma on Tuesday said its board will meet later this week to consider a proposal to raise funds through an issue of securities.
The company's board will meet on September 24 to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof, the company said in a regulatory filing.
The company, however, did not mention the amount it seeks to raise through the issue of securities.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
The company in an investor presentation had stated that it looks to grow consumer healthcare business through line extensions, new launches, and premiumization, by leveraging existing brand equity, additional distribution models.
Mankind also looks to increase the value of prescriptions in the existing market and increase the share of chronic segment by growing presence in existing therapies, as per the presentation.
The company's board will meet on September 24 to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof, the company said in a regulatory filing.
The company, however, did not mention the amount it seeks to raise through the issue of securities.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.
The company in an investor presentation had stated that it looks to grow consumer healthcare business through line extensions, new launches, and premiumization, by leveraging existing brand equity, additional distribution models.
Mankind also looks to increase the value of prescriptions in the existing market and increase the share of chronic segment by growing presence in existing therapies, as per the presentation.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.89 ( 0.00)
- 69758135
- Standard Capital
- 1.26 ( -16.00)
- 55792425
- GTL Infrastructure
- 2.37 (+ 4.87)
- 50169700
- Vodafone Idea L
- 9.18 ( -1.50)
- 27130818
- Jaiprakash Power Ven
- 22.33 ( -2.45)
- 21183721
MORE NEWS
EU Deforestation Rules, Carbon Tax Unfair: Goyal
India's Commerce Minister Piyush Goyal criticizes EU's deforestation regulation and...
Just Dial Q2 Profit Soars 2-Fold to Rs 154 Cr
Just Dial's net profit more than doubled to Rs 154 crore in Q2 FY25, driven by record...
Mandhana Industries Promoter Accused of Loan...
ED chargesheet alleges Purushottam Mandhana diverted business loans for personal gain,...